Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001326732-25-000029
Filing Date
2025-02-27
Accepted
2025-02-27 08:05:38
Documents
120
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xncr-20241231.htm   iXBRL 10-K 2115291
2 EX-4.3 xncr-20241231xexx43.htm EX-4.3 25652
3 EX-10.6 xncr-20241231xexx106.htm EX-10.6 57900
4 EX-10.7 xncr-20241231xexx107.htm EX-10.7 64167
5 EX-10.29 xncr-20241231xexx1029.htm EX-10.29 848406
6 EX-10.30 xncr-20241231xexx1030.htm EX-10.30 24655
7 EX-10.34 xncr-20241231xexx1034.htm EX-10.34 432069
8 EX-19 xncr-20241231xexx19.htm EX-19 103551
9 EX-21.1 xncr-20241231xexx211.htm EX-21.1 2535
10 EX-23.1 xncr-20241231xexx231.htm EX-23.1 2414
11 EX-31.1 xncr-20241231xexx311.htm EX-31.1 10120
12 EX-31.2 xncr-20241231xexx312.htm EX-31.2 10377
13 EX-32.1 xncr-20241231xexx321.htm EX-32.1 4803
14 EX-32.2 xncr-20241231xexx322.htm EX-32.2 5002
20 image_0.jpg GRAPHIC 30268
21 image_1a.jpg GRAPHIC 5519
22 xncr-20241231_g1.jpg GRAPHIC 88145
  Complete submission text file 0001326732-25-000029.txt   13167527

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20241231.xsd EX-101.SCH 84960
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xncr-20241231_cal.xml EX-101.CAL 109303
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xncr-20241231_def.xml EX-101.DEF 448860
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20241231_lab.xml EX-101.LAB 933353
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20241231_pre.xml EX-101.PRE 752820
123 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20241231_htm.xml XML 1536016
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36182 | Film No.: 25673138
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)